Menu Close
December 2023
Very best wishes and many thanks to all our customers and partners
The year 2023 is almost over, with many beautiful but also difficult moments. It has made us realise once again how fragile our world is and how dependent we all are on each other.
September 2023
United Nations International Day of Charity - an inspiring act for philanthropy and values
The International Day of Charity was established with the objective of sensitizing and mobilizing people, NGOs, and stakeholders all around the world to to help others through volunteer and philanthropic activities. The date of 5 September was chosen in order to commemorate the anniversary of the passing away of Mother Teresa of Calcutta.
July 2023
Swiss reimbursement approval for focal HIFU therapy for localised PC
Treatment for high-risk non–muscle-invasive bladder cancer (NMIBC) with hyperthermic intravesical Switzerland has reached another noteworthy milestone in the field of innovative and research-based medicine. As of July 1, 2023, health insurance coverage will be extended to include focal HIFU therapy for localized prostate carcinoma. This marks a significant step forward in providing comprehensive and advanced healthcare services for patients in the country.
April 2023
Life cycle assessment of Swiss hospitals - new study proves marginal impact of disposable materials
The use of healthcare services accounts for more than five percent of Switzerland's consumption-related greenhouse gas emissions.
February 2023
Gold Anchor – the Fiducial Marker for Endoscopic Placement
The Gold Anchor, our innovative fiducial marker, has been placed endoscopically by many leading university hospitals in rectal, pancreatic, esophageal, and central lung tumors.
December 2022
Very best wishes and many thanks to all our customers and partners
May the new year be filled with health, happiness, prosperity, hope and peace! Your innoMedicus.
May 2022
HIVEC therapy using COMBAT BRS is a great alternative to BCG treatment for HR-NMIBC patients
Promising results regarding the treatment of high-risk non-muscle-invasive bladder cancer (HR- NMIBC) patients with recirculating hyperthermic intravesical chemotherapy (HIVEC) with mitomycin C (MMC) as an alternative to intravesical bacillus Calmette–Guérin (BCG) were recently published in the World Journal of Urology.
March 2022
Impressive long-term cancer control data from the largest and longest study of focal HIFU treatment
Encouraging results of long-term cancer control data from the longest study of focal HIFU treatment was recently publishes in European Urology.
February 2022
Promising long-term efficacy of HIVEC therapy using Combat BRS for BCG-unresponsive NMIBC patients
Impressive results regarding long-term efficacy of hyperthermic intravesical chemotherapy (HIVEC) using Combat BRS for BCG-unresponsive, non-muscle invasive bladder cancer (NMIBC) patients was recently published in Urologic Oncology.
December 2021
Many thanks and Christmas greetings to all our customers and partners
As 2021 comes to an end, this is our time to say thank you.
September 2021
Film Kavita & Teresa inspires people to think about true values in life
The film by Swiss-Indian filmmaker Kamal Musale is a contemporary drama and an epic biopic about Mother Teresa, which inspires to look at one's own values and to live compassion, respect and love in one's personal environment. A captivating movie that we at innoMedicus encourage you to watch.
May 2021
World’s largest propensity matched comparison of salvage RARP matched to primary RARP
Encouraging results of the world’s largest propensity matched comparison of salvage robot-assisted radical prostatectomy (RARP) after focal and whole gland nonsurgical primary therapy from the UK group has been published in the European Urology Open Science.
March 2021
Intravesical hyperthermia with high-dose mitomycin-C shows promise as BCG alternative for NMIBC
Treatment for high-risk non–muscle-invasive bladder cancer (NMIBC) with hyperthermic intravesical chemotherapy (HIVEC) using high-dose mitomycin-C (MMC) is safe, well tolerated, and appears efficacious after short-term follow-up, according to a report from Duke University urologists, which has been published in Urologic Oncology.
February 2021
Non-Contrast MRI may have favourable characteristics as a screening test of prostate cancer
The first study to compare bi-parametric MRI, ultrasound and PSA as a screening test for prostate cancer has been recently published in JAMA Oncology.
January 2021
The first U.S. study on focal HIFU therapy has been published since FDA clearance
The publication at The Journal of Urology entitled “High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series” details the study of 100 men with biopsy-confirmed prostate cancer, 72% of which were classified with intermediate or high-risk disease.
December 2020
Many thanks and Christmas greetings to all our customers and partners
This year was a very challenging year for all of us. All the more we would like to thank you for your loyalty and for believing in us.
October 2020
Focal ablative therapy compared to radical prostatectomy provides equivalent oncological outcomes over 8 years
After the tremendous success of the FOCAL2019 in Miami, the annual conference on the Frontiers in Oncologic Prostate Care and Ablative Local Therapy FOCAL2020 took place virtually where a lot of participants from the world over attended this cutting-edge meeting despite Covid-19 restrictions.
September 2020
What Type of Prostate Cancer is Systematically overlooked by mp-MRI?
mpMRI has dramatically changed how urologists diagnose and monitor prostate cancer, as it not only allows lesions to be targeted in biopsies but also helps in deciding which patients to biopsy.
August 2020
Promising results with Combat HIVEC in high risk non-muscle invasive bladder cancer patients
Promising preliminary results from HIVEC-HR randomized trial with 24 months of median follow-up, presented by a group of urologists from the Hospital Universitario 12 de Octubre, Madrid, peaked great interest at AUA 2020, because of the growing need to find a valid alternative to BCG for patients with non-muscle invasive bladder cancer (NMIBC).
July 2020
MRI guided Focal Cryotherapy of Prostate Cancer using Artemis fusion platform
A group of urologists from Weill Cornell Medicine, New York, NY and Urological Research Network, Miami, FL has presented an interesting pilot study of the feasibility and reproducibility of performing MR/US cryoablation using the MR/US fusion from the Artemis® platform in a step-by-step video at AUA University podcast online.
June 2020
Further evidence that surgery after focal therapy for prostate cancer is safe
The great editorial by Dr. Paul Cathcart, a UK expert of salvage robotic radical prostatectomy, has been recently published in the British Journal of Urology International.
May 2020
The first single-use flexible digital cystoscope has arrived
We are delighted to announce the WiScope® single-use digital flexible cystoscope, which recently received EU approval and is based on the same imaging platform as a WiScope® single-use flexible digital ureteroscope.
April 2020
Fight Covid-19 with the help of lung ultrasound
As the global infection rates of COVID-19 continue to rise, investigators in Italy, led by Erika Poggiali, M.D., from Ospedale Guglielmo da Saliceto, evaluated whether lung ultrasound could be an effective tool in also identifying patients who have pneumonia specifically associated with the virus. They published their results in a Letter to the Editor recently in Radiology.
March 2020
Stay safe and be respectful to each other
We continue to monitor the COVID-19 outbreak and are adjusting our business practice in line with directives from the BAG and WHO. It is our goal to give ongoing support to our customers while at the same time ensuring the safety and health of our team members.
February 2020
HIVEC – cystectomy saving alternative for patients with high risk superficial TCC or BCG non-responders
At the ASCO Genitourinary Cancers Symposium 2020 in San Francisco, Prof. Thomas-Alexander Vögeli from the University Hospital RWTH Aachen, Germany presented very promising results of first two year follow up after the Hyperthermic Intra-VEsical Chemotherapy (HIVEC) with heated mitomycin in a cohort of patients with high risk superficial bladder cancer (TCC).
January 2020
Men with prostate cancer willing to prioritise quality over quantity of life
Impressive results of the COMPARE study have recently been published in The Journal of Urology. Prostate cancer patients of all risk groups were willing to trade-off cancer-specific survival for improved quality of life.
December 2019
Many thanks and Christmas greetings to all our customers and partners
As 2019 comes to an end, this is our time to say thank you.
November 2019
MRI-targeted biopsy: attractive and reliable diagnostic strategy for prostate cancer
Two great papers, recently published in European Urology, confirm that MRI-targeted biopsy is the attractive and reliable diagnostic strategy for prostate cancer compared to the traditional diagnostic pathway of systematic TRUS biopsy.
October 2019
New strong clinical data for Sonablate HIFU
New strong clinical data for Sonablate HIFU, recently published in the BJU International, confirms very promising medium-term oncological outcomes.
June 2019
An excellent presentation about Targeted Biopsy and Focal HIFU Therapy Program by UCLA group
At the AUA congress in Chicago, Prof. Leonard Marks and the UCLA group presented a method for focal HIFU, employing multiparametric magnetic resonance imaging, fusion biopsy, margin generation, and targeted treatment.
May 2019
The newest generation single-use flexible ureteroscope has arrived
We are delighted to announce a new partnership with OTU Medical Inc., a Silicon Valley based medical technology company, which recently received the EU approval for its second generation WiScope® single-use flexible digital ureteroscope.
February 2019
Prostate Imaging and Focal Therapy Masterclass at Imperial College London
We’re pleased to announce that the Prostate Imaging and Focal Therapy Masterclass, presented by one of the world’s leading urologists and experts in focal therapy, Prof. Hashim Ahmed, Chair of Urology of Imperial College London, will be returning on the 5-6th April 2019 for its second event.
January 2019
SonoIQ - a small pocket ultrasound to go
SonoIQ, a small pocket Ultrasound, transfers high resolution ultrasound images to Android, iOS or Windows smartphone or tablet via WiFi or USB cable.
November 2018
New study about Gold Anchor confirms low risk of infection and great marker stability
We are happy to share with you a new study about Gold Anchor from the Karolinska University Hospital in Stockholm, Sweden.
Conclusion of the study: The use of thin needles for the implantation of fiducials appears to reduce the rate of infection despite the use of a single dose of non-broad-spectrum antibiotics as prophylaxis. The marker construct appears to provide stability in the tissues.
September 2018
Strong Clinical Data for Sonablate HIFU
The UK urologist group led by University College and Imperial College London published 5-year outcomes from a multicenter study following focal therapy treatment with its Sonablate technology of 625 medium to high-risk clinically significant nonmetastatic prostate cancer patients.